China National Accord Medicines Corp Ltd (200028) — Free Cash Flow Generation Index
China National Accord Medicines Corp Ltd (200028) has a Free Cash Flow Generation Index of 0.97x as of June 2025. Free cash flow of HK$1.78 Billion represents 1% of operating cash flow (HK$1.83 Billion). See China National Accord Medicines Corp Ltd (200028) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China National Accord Medicines Corp Ltd Free Cash Flow Generation Index (1998–2025)
Historical FCF Generation Index trend for China National Accord Medicines Corp Ltd across 27 annual periods. Explore China National Accord Medicines Corp Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for China National Accord Medicines Corp Ltd (1998–2025)
Year-by-year Free Cash Flow Generation Index for China National Accord Medicines Corp Ltd. For the full company profile including market capitalisation, see China National Accord Medicines Corp Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (HKD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.87x | HK$1.42 Billion | HK$1.64 Billion | HK$217.35 Million | ▼ -5.1% |
| 2024 | 0.91x | HK$2.99 Billion | HK$3.27 Billion | HK$282.70 Million | ▲ +2.6% |
| 2023 | 0.89x | HK$2.61 Billion | HK$2.94 Billion | HK$322.21 Million | ▲ +1.8% |
| 2022 | 0.87x | HK$2.24 Billion | HK$2.56 Billion | HK$322.19 Million | ▲ +12.6% |
| 2021 | 0.78x | HK$1.28 Billion | HK$1.66 Billion | HK$370.43 Million | ▼ -3.5% |
| 2020 | 0.80x | HK$1.21 Billion | HK$1.50 Billion | HK$293.83 Million | ▼ -8.3% |
| 2019 | 0.88x | HK$1.76 Billion | HK$2.00 Billion | HK$245.17 Million | ▲ +8.8% |
| 2018 | 0.81x | HK$1.07 Billion | HK$1.32 Billion | HK$255.48 Million | ▼ -4.1% |
| 2017 | 0.84x | HK$1.08 Billion | HK$1.29 Billion | HK$204.35 Million | ▲ +2.6% |
| 2016 | 0.82x | HK$1.21 Billion | HK$1.47 Billion | HK$265.89 Million | ▲ +0.1% |
| 2015 | 0.82x | HK$857.62 Million | HK$1.05 Billion | HK$190.36 Million | ▲ +21.0% |
| 2013 | 0.68x | HK$314.53 Million | HK$465.03 Million | HK$150.50 Million | ▲ +68.1% |
| 2012 | 0.40x | HK$130.38 Million | HK$323.96 Million | HK$193.57 Million | ▲ +222.8% |
| 2011 | 0.12x | HK$28.35 Million | HK$227.32 Million | HK$198.97 Million | ▼ -78.7% |
| 2010 | 0.58x | HK$250.17 Million | HK$428.16 Million | HK$177.99 Million | ▼ -5.8% |
| 2009 | 0.62x | HK$167.91 Million | HK$270.85 Million | HK$102.94 Million | ▼ -5.4% |
| 2008 | 0.66x | HK$161.60 Million | HK$246.58 Million | HK$84.98 Million | ▲ +252.9% |
| 2007 | 0.19x | HK$16.29 Million | HK$87.70 Million | HK$71.41 Million | ▼ -46.9% |
| 2006 | 0.35x | HK$63.51 Million | HK$181.73 Million | HK$118.22 Million | ▼ -46.9% |
| 2005 | 0.66x | HK$97.65 Million | HK$148.28 Million | HK$50.62 Million | ▼ -26.1% |
| 2004 | 0.89x | HK$116.11 Million | HK$130.30 Million | HK$14.18 Million | ▲ +127.2% |
| 2003 | 0.39x | HK$31.86 Million | HK$81.22 Million | HK$49.36 Million | ▲ +504.3% |
| 2002 | 0.06x | HK$1.87 Million | HK$28.76 Million | HK$26.90 Million | ▼ -86.9% |
| 2001 | 0.50x | HK$35.25 Million | HK$71.16 Million | HK$35.91 Million | ▲ +133.8% |
| 2000 | -1.47x | HK$-12.49 Million | HK$8.52 Million | HK$21.01 Million | ▼ -612.6% |
| 1999 | -0.21x | HK$-4.70 Million | HK$22.84 Million | HK$27.54 Million | ▲ +79.3% |
| 1998 | -0.99x | HK$-5.17 Million | HK$5.21 Million | HK$10.38 Million | — |